Paediatrics Search
Paediatrics Paediatrics
hand,%20foot%20-and-%20mouth%20disease
HAND, FOOT & MOUTH DISEASE
Hand, foot and mouth disease (HFMD) is characterized by fever, vesicular stomatitis, and papular/vesicular lesions located peripherally (ie palms of hands, knees, soles of feet, buttocks or genitalia).
Oral vesicular lesions are 1-3 mm, mostly found on the buccal mucosa, tongue and soft palate.
Each oral lesion is surrounded by erythema and is tender to touch.
Patient may complain of sore throat or sore mouth, fever and may be difficult to feed.
Most common cause of HFMD is coxsackievirus A16 (A16).

Hand,%20foot%20-and-%20mouth%20disease Patient Education

Patient Education

  • Inform the parent/guardian of the patient’s diagnosis & the possible complications that may occur
    • Infection caused by EV71 are usually accompanied by neurological complications
    • Infection caused by coxsackievirus A16 is the common hand, foot & mouth disease (HFMD) w/ uneventful clinical course & where full recovery is expected
  • Patient should be brought back for consult if any of the following is observed:
    • High fever
    • Lethargy & weakness
    • Child is difficult to feed
    • Urine output is decreased
    • Rapid breathing
    • Vomiting
    • Drowsiness/irritability
    • Unexplained “fits”
    • Myoclonus jerk
    • Limb paralysis
  • Advise parent/guardian that there is no specific treatment for HFMD
    • Maintain adequate fluid intake to prevent dehydration
    • No vaccine is available against causative agents of HFMD
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Preventive zinc, micronutrient powders do not improve child growth
02 Apr 2019
Using preventive zinc and micronutrient powder supplementation does not appear to improve growth in children, a recent study has found.
Rheuma drug shows disease-modifying potential for T1D
Audrey Abella, 14 Oct 2020
Findings from the phase IIa T1GER study revealed the therapeutic potential of the monoclonal antibody golimumab for children and young adults with type 1 diabetes (T1D).
Amoxicillin-clavulanate regimen for PBB: 4 weeks no better than 2 weeks
Roshini Claire Anthony, 28 Sep 2020

A 4-week course of amoxicillin-clavulanate in children with protracted bacterial bronchitis (PBB) does not improve cough resolution rates compared with a 2-week course, according to a study from Australia. However, the longer course may significantly extend time to first cough exacerbation.